ORBI-PHARMA INTERNATIONAL
ActiveSummary
ORBI-PHARMA INTERNATIONAL has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€247,268) and a net result of -€42,359. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 10,757 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Group and network
Connections & network
2 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.